J. Oger

Neutralizing antibodies and interferon treatment of multiple sclerosis: addressing the open questions
Mult Scler 2007 13: 5-7. [PDF] [References]  

A. AL-Sabbagh

Neutralizing antibodies in MS therapy: reviewing the Rebif experience
Mult Scler 2007 13: 8-13. [Abstract] [PDF] [References]  

Suzan E. Goelz and L. Walt

Development of neutralizing antibodies to intramuscular interferon beta-1a (Avonex ®)
Mult Scler 2007 13: 14-20. [Abstract] [PDF] [References]  

M. Cantillon and I. Antonijevic

Clinical relevance of anti-drug antibodies with interferon beta-1b therapy in multiple sclerosis
Mult Scler 2007 13: 21-27. [Abstract] [PDF] [References]  

F. Blanchette

Clinical significance of glatiramer acetate antibodies
Mult Scler 2007 13: 28-35. [Abstract] [PDF] [References]  

J. Oger and E. Gibbs

Binding antibodies: Vancouver's perspective
Mult Scler 2007 13: 36-43. [Abstract] [PDF] [References]  

Florian Deisenhammer

Neutralizing antibody (NAb) assays in multiple sclerosis patients receiving interferon-ß therapy
Mult Scler 2007 13: 44-48. [Abstract] [PDF] [References]  

A.R. Pachner

Real-time TaqMan assay for myxovirus resistance protein (MxA) mRNA: a robust marker of interferon beta bioactivity in patients with multiple sclerosis
Mult Scler 2007 13: 49-52. [Abstract] [PDF] [References]  

A.T. Reder

Neutralizing antibodies in multiple sclerosis: a complex impact on interferon responses, magnetic resonance imaging findings and clinical outcomes
Mult Scler 2007 13: 53-62. [Abstract] [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.